Compound ID | 413

Update compound information

LB 10827

Class: Beta-lactam

Agent Type: Semisynthetic; Small molecule; Direct acting;
Spectrum of activity: Gram-positive
Mechanism of action: Cell wall synthesis inhibitor
Target Pathogen: Active against pathogen causing community-acquired pneumoniae
Description: Oral cephalosporin
Institute where first reported: LG Life Sciences, South Korea
Year first mentioned: 1999
Development status: Experimental
Chemical structure(s):
Click here for structure editor
Molecular weight: 590.08
Iso. SMILES: C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)/C(=N\O)/C3=C(SC(=N3)N)Cl)C(=O)O)SCSC4=NC(=NC(=C4)N)N
InChI Key: OBZREKINKKRXQH-SJCJUFQRSA-N
Can. SMILES: C1=C(N=C(N)N=C1N)SCSC2=C(C(=O)O)N3C(=O)[C@H]([C@H]3SC2)NC(=O)/C(=N\O)/C4=C(Cl)SC(=N4)N
InChI: InChI=1S/C17H16ClN9O5S4/c18-11-7(25-17(21)36-11)8(26-32)12(28)24-9-13(29)27-10(15(30)31)4(2-33-14(9)27)34-3-35-6-1-5(19)22-16(20)23-6/h1,9,14,32H,2-3H2,(H2,21,25)(H,24,28)(H,30,31)(H4,19,20,22,23)/b26-8-/t9-,14-/m1/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/9851428
Citation: https://journals.asm.org/doi/10.1128/aac.44.12.3272-3277.2000

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.